The aim of this review was the evaluation of benefits and harms of low-dose-rate permanent interstitial brachytherapy in localised prostate cancer compared with standard surgical procedures, percutaneous radiotherapy, and watchful waiting.
The focus of the evaluation was on patient-relevant therapy goals. Moreover, substantially different types of brachytherapy were to be compared with each other.
Reference: Executive summary of final report N04-02, Version 1.0
PubMed Abstract
PMID: 23101085
UroToday.com Prostate Cancer Section
